Product Code: RP-ID-10352010 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10352010
Market Overview:
Global Minimally Invasive Glaucoma Surgery Devices Market Analysis & Outlook 2030
The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is estimated at USD 180 million in 2021, and is anticipated to expand at a CAGR of 33% from 2022 to 2030. Insignificantly obtrusive glaucoma medical procedure (MIGS) gadgets can be are utilized in any glaucoma medical procedure that dodges conjunctival analyzation, and incorporates an abdominal muscle interno cut for the therapy of patients experiencing glaucoma. The approach of MIGS gadgets has changed the patients care with gentle to-direct glaucoma conditions. What's more, further developed security profile just as less time needed for recuperation after medical procedure when contrasted with more obtrusive strategies expands the interest for MIGS gadgets. This pushes makers to present effective MIGS gadgets like stents, shunts, and negligibly obtrusive inserts on the lookout. Also, glaucoma is the essential driver of irreversible visual deficiency across the globe, and it was assessed that around 5% of the worldwide populace experienced glaucoma in 2020. This has expanded the interest for MIGS gadgets in the treatment of glaucoma.
The key factors that help the market development remember ascend for weight of geriatric populace that is vulnerable to glaucoma. Moreover, meta-examination acted in 2014 presumed that number of individuals experiencing glaucoma is projected to increment throughout the long term particularly in the nations of Asia-Pacific, and Africa. Additionally, ascend sought after for medical procedures joining glaucoma, and waterfall supports the market development. Be that as it may, ominous repayment for negligibly obtrusive glaucoma medical procedure gadgets is expected to hamper the market development. Further, high inclination showed by patients for careful treatment of glaucoma when contrasted with glaucoma meds offers worthwhile freedoms for the development of the market.
Medical procedure Segment Review:
In light of a medical procedure, the negligibly intrusive glaucoma medical procedure (MIGS) gadgets market is separated into glaucoma related to waterfall and independent glaucoma. Glaucoma related to waterfall fragment overwhelms the worldwide MIGS market in 2016, and is expected to keep up with this strength all through the figure period. Notwithstanding, expansion in research on the capability of stents in lessening the IOP during independent glaucoma medical procedures is seen in the new years. This adds to the strong development of the independent glaucoma medical procedures section in the worldwide MIGS gadgets market.
Item Form Segment Revie:
The insignificantly intrusive glaucoma medical procedure (MIGS) gadgets market sectioned dependent on item, is isolated into MIGS stents, MIGS shunts, and other. Different items used in insignificantly intrusive glaucoma medical procedures incorporate new laser strategies, miniature inserts, and microcatheters. MIGS stents portion created the most noteworthy income in 2016, and is expected to keep up with the pattern all through the figure period. Stents are used for huge scope in the negligibly intrusive glaucoma medical procedures. The most broadly acknowledged stents incorporate iStent (Glaukos Coproration), CyPass MicroStent (Alcon/Novartis), and Hydrus Microstent (Irvine).
In light of geology, the insignificantly obtrusive glaucoma medical procedure (MIGS) gadgets market is dissected across North America, Europe, Asia-Pacific, and LAMEA. North America overwhelmed the market representing most elevated offer in 2016, and is expected to proceed with its strength all through the conjecture period. While, Asia-Pacific enlisted quickest development from 2022-2030.
The report gives an exhaustive examination of the central members working in the worldwide insignificantly obtrusive glaucoma medical procedure (MIGS) gadgets market like Alcon Inc. (Novartis), Ellex Medical Lasers Ltd., Glaukos Corporation, Allergan Plc, Santen Pharmaceutical Co., Ltd., Lumenis, Ivantis, Inc., SOLX, Inc, iSTAR Medical, and InnFocus Inc. Different parts in the worth chain incorporate Bausch and Lomb Inc., Neomedix Corporation, IOPtima, Abbott Medical Optics, Inc., Topcon Corporation, New World Medical, Inc, Carl-Zeiss AG, and Optonol Ltd.
Key Benefits:
The investigation furnishes a top to bottom examination with the latest things and future assessments of the worldwide insignificantly intrusive glaucoma medical procedure (MIGS) gadgets market to clarify the fast approaching speculation pockets. Thorough investigation of the components that drive and confine the market development is given.
The quantitative examination of the business from 2022-2030 is given to empower the partners to profit by the overarching market openings. Broad examination of key sections of the business is given to comprehend the sorts of negligibly obtrusive glaucoma medical procedure (MIGS) gadgets utilized all around the world.
Central participants and their systems are dissected to comprehend the cutthroat viewpoint of the market.
Insignificantly Invasive Glaucoma Surgery (MIGS) Devices Market Key Segments:
By Surgery
Glaucoma in Conjunction with Cataract
Remain solitary Glaucoma
By Target
Trabecular Meshwork
Suprachoroidal Space
Others
Result
MIGS Stents
MIGS Shunts
Other
By End User
Eye Hospitals
Ophthalmology Clinics
Outpatient Surgical Centers
Related Reports
Proof of Quality & Reliability
